Prosight Management, LP Moderna, Inc. Transaction History

Prosight Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $467,902 - $869,685	-3,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $835,534 - $1.36 Million	3,700 New	3,700 $940,000
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $18,997 - $32,360	-174 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $11,438 - $29,555	174 New	174 $18,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.